Strydex

The Challenge:
Over 5 million Pakistanis — and 250 million people worldwide — suffer from lower-limb mobility issues caused by stroke, arthritis, diabetic neuropathy, spinal injuries, and other gait impairments.Rehabilitation is slow, expensive, and often abandoned due to poor personalization.
Our Solution:
Affordable, AI-powered walking assist exoskeletons that support patients in physiotherapy and daily
mobility.
Why It Works:
– Learns and predicts each patient’s walking patterns using AI/deep learning
– Provides assistive force with high-quality motors
– Tracks progress for patients and physiotherapists
– Lightweight, non-invasive, and usable outside hospitals
Market Size:
– TAM: $15.4B (Exoskeletons + Prosthetics/Orthotics + Physiotherapy)
– SAM: $1.5B (Exoskeleton market in U.S., U.K., APAC)
– SOM: $1.02M (Pakistan hospital & clinic outreach)
Target Audience:
Hospitals, rehabilitation centers, physiotherapy clinics, and patients with lower-limb mobility
challenges.
Go-To-Market:
– B2B: Subscription-based hospital deployments
– B2C: Affordable sales/leases for at-home rehabilitation
Revenue Model:
Device sales, subscriptions, and lease-to-own plans.
Traction:
– 7 patients in clinical trials
– 3 hospitals partnered, 2 MoUs signed
– Winner, Ideation Category — SEE Pakistan 2025
– PKR 1.7M raised (Seed + prize)
Funding Required: $300,000
Use of Funds:
– Product Development (40%)
– Clinical Trials & Pilots (25%)
– Manufacturing & Supply Chain (15%)
– Sales & Marketing (10%)
– Operations & Regulatory Approvals (10%)
Contact:
For more information, please reach out to Startup Growth Manager at
baber.mushtaq@change.mechanics.pk